TROG Cancer Research
Members Login   CQMS Login

Completed trials

If you or a family member participated in one of these trials and would like to know the results, please contact the study doctor reponsible for the study at your treatment centre.

TROG 04.01  
A Paired Double Blind Randomised Comparison of Cavilon Durable Barrier Cream (CDBC) to 10% Glycerine (“Sorbolene”) Cream in the Prophylactic Management of Post-Mastectomy Irradiation Skin Care.
TROG 03.08  
A phase III international randomized trial of single versus multiple fractions for re-irradiation of painful bone metastases.
TROG 03.07  
A Randomised Phase II Study of Two Regimens of Palliative Chemoradiation Therapy in the Management of Locally Advanced Non Small Cell Lung Cancer
TROG 03.06  
 A collaborative randomised phase III trial: The timing of intervention with androgen deprivation in prostate cancer patients with a rising PSA.
TROG 03.02  
A Feasibility Study to Evaluate Adjuvant chemo-radiotherapy for Gastric Cancer
TROG 02.02  
Phase III Randomized Trial of Concomitant Radiation, Cisplatin, and Tirapazamine (SR259075) Versus Concomitant Radiation and Cisplatin in Patients With Advanced Head and Neck Cancer
TROG 02.01
A Randomised Clinical Trial of Surgery Versus Surgery Plus Adjuvant Radiotherapy for Regional Control in Patients With Completely Resected Nodal Metastatic Melanoma
TROG 01.05  
A Pilot Randomised Controlled Trial of Dexamethasone 96mg Versus 16mg Per Day for Malignant Spinal Cord Compression Treated by Radiotherapy - TROG SuperDex Pilot
TROG 01.03  
Concomitant and Adjuvant Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme. A Randomized Phase III Study
TROG 01.01  
A Phase III Double-Blind, Randomized, Placebo-Controlled Study of Erythropoietin When Used as an Adjuvant to Radiation Therapy in Patients With Head & Neck Squamous Cell Carcinoma
TROG 99.06  
Phase I/II Study of Trans-Urethral Resection Followed by Modified Synchronous Chemo-Radiation in the Definitive Management of Localised Invasive TCC of the Urinary Bladder
TROG 99.05  
Tumour Volume as an Independent Prognosis Factor in Patients with Non-Small Cell Lung Cancer: A Protocol for a Progressive Database
TROG 99.04  
A Prospective, Non-Randomised Study of Chemotherapy and Radiotherapy for Osteolymphoma (OL)
TROG 99.02  
A Prospective Single Arm Non Randomised Study of Concurrent Radiation and Chemotherapy For the Organ Conserving Treatment of Early Anal Canal Cancer
TROG 99.01  
An ANZLG / TROG Prospective Study of Limited Chemotherapy and Involved Field Radiotherapy for Patients With Clinical Stage I-II Hodgkin’s Disease
TROG 98.06  
Concurrent Radiotherapy and Chemotherapy for Oesophageal Cancer Patients
TROG 98.05  
A Randomised Trial of Immediate Versus Delayed Whole Brain Irradiation Following Surgery and/or Radiosurgery for patients with one or two brain metastases.
TROG 98.04  
Phase II Study Examining the Efficacy of Short Fractionation Radiotherapy for the Palliation of Liver Metastases
TROG 98.03  
Randomised Trial to Compare the Rates of Disease-Free Survival in Margine-Positive Patients After Radical Prostatectomy With or Without Adjuvant Post-Operative Radiotherapy
TROG 98.02  
Randomised Phase II Study of Two Different Strategies for Chemoradiotherapy in Advanced Squamous Cell Carcinoma of the Head and Neck
TROG 98.01  
A Phase II Trial Of Preoperative Radiotherapy With Protracted Infusion 5-Fluorouracil For Resectable Adenocarcinoma Of Rectum
TROG 97.01  
A Phase II Study of Trans-Urethral Resection Followed by Synchronous Chemo-Radiation in the Definitive Management of Localised Invasive TCC of the Urinary Bladder
TROG 96.07  
A Phase II Study of Synchronous Carboplatin/Etoposide And Radiation In Merkel Cell Carcinoma Of The Skin
TROG 96.06  
A Phase II Study of Radiation Therapy Following Nodal Surgery in Malignant Melanoma
TROG 96.05  
A Prospective Randomised Trial of Single Fraction Verses Fractionated Radiotherapy of Neuropathic Pain Due to Bone Metastases
TROG 96.04  
Phase III Comparison of Radiotherapy with Glucocorticoid Steroid Support for the Palliation of Liver Metastases
TROG 96.03  
Concomitant Accelerated Radiotherapy Boost for Good Prognosis Oesophageal Patients
TROG 96.02  
Standard Radio-Chemotherapy for Oesophageal Cancer Patients
TROG 96.01  
A Randomised Trial Investigating the Effectiveness of Different Durations of Maximal Androgen Deprivation Prior to and During Definitive Radiation Therapy for Locally Advanced Carcinoma of the Prostate
TROG 95.03  
Phase III Double Blind Study of Pentosan Polysulphate Sodium (PPS) in the treatment of Late (Chronic ) Radiation Proctitis
TROG 95.02  
A Phase III Double-Blind Randomised Trial of Rectal Sucralfate Suspension in the Treatment of Radiation Proctitis
TROG 95.01  
A Randomised Trial Comparing Adjuvant Protracted Venous Infusion and Bolus 5FU/Leucovorin with Either Early or Late Radiotherapy in Rectal Cancer
TROG 94.01  
A Randomised Phase III Clinical Trial  Comparing Surgery Alone with Concurrent Preoperative  Chemotherapy and Radiation Followed by Surgery  For Localised Resectable Carcinoma of the Oesophagus
TROG 92.01  
A Phase II Study of Intravenous Methotrexate and Cranial Irradiation in the Treatment of Primary Central Nervous System Lymphoma (PCNSL)
TROG 91.01  
A Phase III Prospective Randomised Clinical Trial of Accelerated Radiotherapy (ART) for Stage III and IV Squamous Carcinoma of the Upper Aerodigestive Tract
TROG 89.04  
Synchronous Radiotherapy and Chemotherapy in Oesophageal Cancer
TROG 89.03  
Upper Aero-Digestive Track (Accelerated RT)
TROG 89.02  
Simultaneous Adjuvant Radiation and CMF Chemotherapy Following Surgery for Breast Cancer


We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.